Principle Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,550
| Closed | -$209K | – | 304 |
|
|
2022
Q1 | $209K | Sell |
4,550
-791
| -15% | -$36.3K | 0.02% | 304 |
|
|
2021
Q4 | $327K | Sell |
5,341
-5,735
| -52% | -$351K | 0.03% | 245 |
|
|
2021
Q3 | $828K | Sell |
11,076
-2,488
| -18% | -$186K | 0.1% | 146 |
|
|
2021
Q2 | $1.26M | Buy |
13,564
+3,286
| +32% | +$304K | 0.14% | 117 |
|
|
2021
Q1 | $912K | Buy |
10,278
+4,834
| +89% | +$429K | 0.11% | 132 |
|
|
2020
Q4 | $508K | Buy |
5,444
+1,117
| +26% | +$104K | 0.07% | 175 |
|
|
2020
Q3 | $276K | Buy |
4,327
+275
| +7% | +$17.5K | 0.08% | 127 |
|
|
2020
Q2 | $211K | Buy |
+4,052
| New | +$211K | 0.06% | 141 |
|
|
2020
Q1 | – | Sell |
-6,395
| Closed | -$214K | – | 141 |
|
|
2019
Q4 | $214K | Buy |
+6,395
| New | +$214K | 0.07% | 154 |
|
|
2019
Q3 | – | Sell |
-6,395
| Closed | -$220K | – | 166 |
|
|
2019
Q2 | $220K | Buy |
+6,395
| New | +$220K | 0.11% | 127 |
|